Follow The Filings

ARDX Ardelyx Inc.

Health Care, filed as ARDELYX INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2, sold by 1

  • 1 Owner
  • Max 1.0%
  • $2.7M
  • 1 add 1 exit

In 2026 Q2 Michael Krensavage added to Ardelyx, while Farallon Capital Management sold out.

Who owns this now

Largest portfolio weights among holders, up to 1.0% (Michael Krensavage, Krensavage Asset Management). Not free-float ownership.

  1. Michael Krensavage Add 1.0%

Who owns ARDX

Sorted by value, long equity only, as of 2026 Q2.

History
Michael Krensavage, Krensavage Asset Management 1.0% Add +6.9% 534,523 $2.7M History
Farallon Capital Management exited 2026 Q2 Last 2026 Q1 <0.01% Exit 0.00% 23,000 $138K History

1 current, 1 exited last period, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by ARDX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ARDX insider trades
  • $1.9M bought by 1 insider
  • None no sales outside a trading plan
  • $2.3M sold by 2 insiders under 10b5-1 plans
  1. Michael Raab CEO
    Planned sale
    $211K 41,668 shares at $5.06 2.4% of stake
    Traded Jul 15 Filed Jul 17
    ↗
  2. Laura A Williams Chief Patient Officer
    Planned sale
    $490K 81,898 shares at $5.99 18% of stake
    Traded Jun 18 Filed Jun 22
    ↗
  3. Michael Raab CEO
    Planned sale
    $236K 41,666 shares at $5.67 2.4% of stake
    Traded Jun 15 Filed Jun 17
    ↗
  4. Michael Raab CEO
    Planned sale
    $262K 41,666 shares at $6.28 2.3% of stake
    Traded May 15 Filed May 19
    ↗
  5. Michael Raab CEO
    Planned sale
    $262K 41,668 shares at $6.29 2.3% of stake
    Traded Apr 15 Filed Apr 17
    ↗
  6. Michael Raab CEO
    Planned sale
    $243K 41,666 shares at $5.84 2.2% of stake
    Traded Mar 16 Filed Mar 18
    ↗
  7. Michael Raab CEO
    Planned sale
    $261K 41,666 shares at $6.26 2.2% of stake
    Traded Feb 24 Filed Feb 25
    ↗
  8. David M Mott Director
    Buy
    $1.9M 333,333 shares at $5.84 +11% to stake
    Traded Feb 20 Filed Feb 23
    ↗
  9. Laura A Williams Chief Patient Officer
    Planned sale
    $349K 50,000 shares at $6.98 12% of stake
    Traded Jan 8 Filed Jan 9
    ↗

Also filed in the last 12 months, not counted as buying or selling: 70 sales to cover taxes, 17 stock grants, and 8 option exercises.

Congress

No member of Congress reported trading ARDX in the last three years. 1 member listed it in 2025 annual reports.

All Congress trades

SEC filings

Recent issuer filings from EDGAR, 13 shown.

Filed Form Detail Links
8-K 8.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.03,9.01 Filing Doc
8-K 5.02,5.07 Filing Doc
DEFA14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc

Source: SEC EDGAR submissions, updated 13 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $124.46M $333.62M $407.32M
Net income -$66.07M -$39.14M -$61.6M
Net margin * -53.1% -11.7% -15.1%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $246.11M $356.45M $382.32M
Total non-current assets * $51.47M $79.3M $119.29M
Total assets $297.58M $435.75M $501.6M
Total current liabilities $50.39M $77.83M $88.6M
Total non-current liabilities * $80.37M $184.64M $246.05M
Total equity $166.82M $173.29M $166.95M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$89.72M -$44.81M -$42.48M
Cash from investing -$131.25M -$18.32M -$8.96M
Cash from financing $146.3M $106.59M $54.51M
Net change in cash -$74.67M $43.46M $3.07M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.